These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10513252)

  • 21. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The process of drug development. The "case" of spironolactone].
    De Feo S; Opasich C; Volpi A; Tavazzi L
    Ital Heart J Suppl; 2002 Feb; 3(2):178-86. PubMed ID: 11926024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone antagonism and atrial fibrillation: time for clinical assessment?
    Nattel S
    Eur Heart J; 2005 Oct; 26(20):2079-80. PubMed ID: 16141259
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on the treatment of heart failure.
    Havranek EP; Weinberger J
    Prog Cardiovasc Nurs; 1999; 14(3):111-3. PubMed ID: 10549049
    [No Abstract]   [Full Text] [Related]  

  • 26. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
    Masoudi FA; Gross CP; Wang Y; Rathore SS; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Jul; 112(1):39-47. PubMed ID: 15983243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of heart insufficiency using aldosterone antagonists].
    Krauss J
    Z Allgemeinmed; 1973 Jul; 49(21):989-91. PubMed ID: 4756071
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H; Balaban Y
    Heart; 2010 May; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract]   [Full Text] [Related]  

  • 30. [Remarks on the use of a new inhibitor of aldosterone in cardiology].
    Broustet P; Besse P; Broustet JP
    Coeur Med Interne; 1969 Jan; 8(1):115-21. PubMed ID: 5768516
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the mechanism of action of antialdosterone compounds (aldactone and progesterone) in the treatment of cardiac edema].
    Gerasimova EN; Kononiachenko VA
    Ter Arkh; 1966 Apr; 38(4):112-8. PubMed ID: 5984655
    [No Abstract]   [Full Text] [Related]  

  • 32. Considerations of aldosterone in congestive heart failure, arrhythmias and sudden cardiac death. Editorial overview.
    Castaigne A
    Am J Cardiol; 1990 Jun; 65(23):39K-40K. PubMed ID: 2353667
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of cardiac edemas by a combination of micronized aldactone and Altizide].
    Soulié P; Gaudeau S
    Coeur Med Interne; 1965 Apr; 4(2):209-13. PubMed ID: 5827838
    [No Abstract]   [Full Text] [Related]  

  • 34. Spironolactone.
    Noerr B
    Neonatal Netw; 1999 Apr; 18(3):43-6. PubMed ID: 10418436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate renal insufficiency does not attenuate the clinical benefit of aldosterone antagonists in heart failure.
    Kiernan MS; Konstam MA
    J Am Coll Cardiol; 2012 Nov; 60(20):2090-1. PubMed ID: 23083776
    [No Abstract]   [Full Text] [Related]  

  • 36. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diuretics in the therapy of chronic cardiac insufficiency].
    Herbinger W
    Wien Med Wochenschr; 1982 Oct; 132(19):457-64. PubMed ID: 7179996
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical use of an anti-aldosterone medication in a micronised form].
    Ruel P
    Lyon Med; 1971 Nov; 226(17):573-80. PubMed ID: 5134687
    [No Abstract]   [Full Text] [Related]  

  • 39. Spironolactone for heart failure: spiraling out of control.
    Geraci JM; Knowlton AA
    Chest; 2000 Dec; 118(6):1522-3. PubMed ID: 11115427
    [No Abstract]   [Full Text] [Related]  

  • 40. Early uptake of research findings after fast-track publication.
    Ghali WA; Cornuz J
    Lancet; 2000 Feb; 355(9203):579-80. PubMed ID: 10683036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.